Systematic review and meta-analysis of prognostic markers in transthyretin amyloid cardiomyopathy

doi:10.4330/wjc.v18.i5.119863

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 5

This Article

(0) (0) (0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (214)

All Articles published online

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-2)

Sum=43

Featured Article

Item

Count

Browse

Download

119

Sum=157

Publishing Process of This Article

Item

Count

Browse

Download

Sum=31

May 26, 2026 (publication date) through May 23, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Cardiol. May 26, 2026; 18(5): 119863
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119863

Open in New Tab Full Size Figure Download Figure

Figure 1 PRISMA diagram showing flowchart of final studies included in this systematic review.

Open in New Tab Full Size Figure Download Figure

Figure 2 Forrest plot. A: Gillmore stage 2 vs 1; B: Gillmore stage 3 vs 1; C: Gillmore stage 3 vs 2; D: B type Natriuretic peptide; E: N Terminal pro-B Type Natriuretic peptide; F: Estimated glomerular filtration rate; G: Troponin T; H: Left ventricular ejection fraction; I: Interventricular septal diameter; J: Posterior wall thickness; K: New York Heart Association class. BNP: B type Natriuretic peptide; NT-proBNP: N Terminal pro-B Type Natriuretic peptide; eGFR: Estimated glomerular filtration rate; LVEF: Left ventricular ejection fraction; IVSd: Interventricular septal diameter; PWT: Posterior wall thickness; NYHA: New York Heart Association.

Citation: Dalia T, Kohli V, Goyal A, Yarrarapu SNS, Singh H, Mancuso J, Malhotra A, Schram J, Bansal P, Shah Z. Systematic review and meta-analysis of prognostic markers in transthyretin amyloid cardiomyopathy. World J Cardiol 2026; 18(5): 119863
URL: https://www.wjgnet.com/1949-8462/full/v18/i5/119863.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i5.119863

Dalia T, Kohli V, Goyal A, Yarrarapu SNS, Singh H, Mancuso J, Malhotra A, Schram J, Bansal P, Shah Z. Systematic review and meta-analysis of prognostic markers in transthyretin amyloid cardiomyopathy. World J Cardiol 2026; 18(5): 119863 [DOI: 10.4330/wjc.v18.i5.119863]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.